Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Antisense mediated exon skipping therapy for duchenne muscular dystrophy (DMD)
Camilla Brolin, Takehiko Shiraishi
Transcription, RNA, and Gene Medicine Program
8
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Antisense mediated exon skipping therapy for duchenne muscular dystrophy (DMD)'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Duchenne Muscular Dystrophy
84%
Dystrophin
67%
Exons
60%
Antisense Oligonucleotides
41%
Peptide Nucleic Acids
26%
Morpholinos
23%
Muscle Proteins
21%
Animal Models
12%
Therapeutics
11%
Mutation
10%
In Vitro Techniques
7%
Genes
7%
Chemical Compounds
Antisense Oligonucleotide
100%
Peptide Nucleic Acid
45%
Lethal
42%
Mutation
30%
Oligomer
28%
Protein
14%